Cargando…

Response to Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”

Detalles Bibliográficos
Autores principales:	Wilson, Jessica R, Shuey, Megan M, Brown, Nancy J, Devin, Jessica K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letter to the Editor-Response
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049288/ https://www.ncbi.nlm.nih.gov/pubmed/32133430 http://dx.doi.org/10.1210/jendso/bvaa006

Ejemplares similares

Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin
por: Wilson, Jessica R., et al.
Publicado: (2017)

Letter to the editor response
por: Krawiec, Conrad, et al.
Publicado: (2022)

Dipeptidyl Peptidase‐4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women
por: Wilson, Jessica R., et al.
Publicado: (2018)

Letter to the Editor
por: Etchison, William C.
Publicado: (2011)

Letter to the Editor: Response
por: Burns, Scott A., et al.
Publicado: (2012)

Response to Letter to the Editor
por: Bozkurt, Banu, et al.
Publicado: (2020)

Response to letter to the editor
por: Dadich, Ann, et al.
Publicado: (2021)

MON-474 Dipeptidyl Peptidase-4 (DPP4) Inhibition Decreases Visceral Fat and Improves Glucose Metabolism in Overweight Women with Polycystic Ovarian Syndrome
por: Devin, Jessica, et al.
Publicado: (2019)

Response: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)
por: Yagi, Shusuke, et al.
Publicado: (2015)

Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010)

Letter to the Editor
por: Tolstrup Larsen, Rasmus
Publicado: (2018)

Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-Related Factors in Health Screen Examinees (J Obes Metab Syndr 2017;26:188-96)
por: Lee, Ji Yeon, et al.
Publicado: (2018)

Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin
por: Tatosian, Daniel A., et al.
Publicado: (2013)

Letter to the Editor: Response
por: Aune, Kyle T., et al.
Publicado: (2018)

Response to the Letter to the Editor regarding ‘The factor structure of complex posttraumatic stress disorder in traumatized refugees’
por: Nickerson, Angela, et al.
Publicado: (2017)

Letter to the Editor Response Regarding “Research Equity in Otolaryngology–Head and Neck Surgery”
por: Patterson, Rolvix Harlan, et al.
Publicado: (2021)

Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
por: Suh, Sunghwan, et al.
Publicado: (2015)

Letter to the Editor: Authors' Response
por: Cetin, Mehtap Bilgin, et al.
Publicado: (2022)

Letter to the Editor, International Journal of COPD [Response to Letter]
por: Llordés, Montserrat, et al.
Publicado: (2020)

Letter to the Editor: Other Interventions in Approach to Lumbar Disorders
por: Kordi, Ramin, et al.
Publicado: (2012)

Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
por: Chung, Yoo-Ri, et al.
Publicado: (2019)

Response to Letter to the Editor: Actioning our understanding of respiratory compromise
Publicado: (2019)

Authors’ response to Ashley Roberts’ letter to the editor on aspartame and cancer
por: Landrigan, Philip J., et al.
Publicado: (2021)

Dipeptidyl‐Peptidase 4 Inhibition and the Vascular Effects of Glucagon‐like Peptide‐1 and Brain Natriuretic Peptide in the Human Forearm
por: Devin, Jessica K., et al.
Publicado: (2014)

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes
por: Kubota, Yoshiaki, et al.
Publicado: (2012)

Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
por: Mega, Cristina, et al.
Publicado: (2017)

“Anterior Chamber Depth After Phacovitrectomy” – Response to Letter to the Editor [Response to Letter]
por: Katz, Gabriel, et al.
Publicado: (2021)

Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
por: John, Christy V., et al.
Publicado: (2023)

Response to letter to the editor “Calcitonin gene-related peptide and traumatic brain injury”
por: Jia, Pi-Feng
Publicado: (2019)

Sitagliptin (MK0431) Inhibition of Dipeptidyl Peptidase IV Decreases Nonobese Diabetic Mouse CD4(+) T-Cell Migration Through Incretin-Dependent and -Independent Pathways
por: Kim, Su-Jin, et al.
Publicado: (2010)

Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase‐4 inhibitor
por: Maita, Hiroki, et al.
Publicado: (2021)

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
por: Komatsu, Tomohiro, et al.
Publicado: (2023)

Response to the Letter to the Editor From Jialal and Sood: “New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency After ACTH Stimulation Using Specific Cortisol Assays”
por: Javorsky, Bradley R, et al.
Publicado: (2021)

Response to Letter to the Editor: “A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness”
por: Hirschhorn, Joel N, et al.
Publicado: (2020)

Response to Letter to the Editor entitled “Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor Like1-Positive Membranous Nephropathy”
por: Ueda, Hiroyuki
Publicado: (2023)

Response to Letter to the Editor: “Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure—A Case Series”
por: Wissner Greene, Loren, et al.
Publicado: (2019)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
por: Evoy, Kirk E, et al.
Publicado: (2021)

Response to Letter to the Editor: “Predictors of Postoperative Diabetes Insipidus Following Endoscopic Resection of Pituitary Adenomas”
por: Nayak, Pratima, et al.
Publicado: (2019)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
por: Garg, Vishvas
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4pmeo7vfe36vuc2u6ovrqkulsm